Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009-Reference-Cited by-同舟云学术

Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009

Author:

Wirtz Veronika J.¹,Mol Peter G. M.²,Verdijk Jonneke³,Vander Stichele Robert H.⁴,Taxis Katja³

Affiliation:

1. Center for Health Systems Research, National Institute of Public Health Cuernavaca; Morelos; Mexico

2. Clinical Pharmacology; University Medical Centre Groningen; University of Groningen; Groningen; The Netherlands

3. Pharmacotherapy and Pharmaceutical Care; University of Groningen; Groningen; The Netherlands

4. Heymans Institute of Pharmacology; Ghent University; Ghent; Belgium

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

Reference36 articles.

2. Center for Disease Control 2012 Interagency task force on antimicrobial resistance http://www.cdc.gov/drugresistance/actionpla/taskforce.html

4. Phenylbutazone and oxyphenbutazone: time to call a halt;Drug and Therapeutic Bulletin;Drug and Therapeutic Bulletin,1984

5. Multicenter study on self-medication;DURG-LA;Clinical Pharmacology and Therapeutics,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Equitable Access to Essential Medicines and Health Technologies;Making Health Systems Work in Low and Middle Income Countries;2022-12-29